Public Profile

Ipca Laboratories

Ipca Laboratories Limited, headquartered in Mumbai, India, is a prominent player in the pharmaceutical industry, specialising in the manufacture and export of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1949, the company has achieved significant milestones, including a robust presence in over 100 countries and a diverse product portfolio that encompasses a wide range of therapeutic areas such as cardiovascular, anti-infective, and pain management. With a commitment to quality and innovation, Ipca Laboratories stands out for its extensive range of generic formulations and APIs, which are produced in state-of-the-art facilities adhering to international standards. The company has garnered a strong market position, recognised for its consistent growth and contributions to healthcare, making it a trusted name in the global pharmaceutical landscape.

DitchCarbon Score

How does Ipca Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

24

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Ipca Laboratories's score of 24 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

36%

Let us know if this data was useful to you

Ipca Laboratories's reported carbon emissions

In 2023, Ipca Laboratories reported total carbon emissions of approximately 124,880,000 kg CO2e for Scope 1 and about 179,114,000 kg CO2e for Scope 2. This reflects a decrease in Scope 1 emissions from 151,862,000 kg CO2e in 2022, while Scope 2 emissions saw a slight increase from 174,694,000 kg CO2e in the previous year. The company has set ambitious climate commitments, aiming for a 20% reduction in carbon emissions across both Scope 1 and Scope 2 by 2030, with the baseline year being 2022. This commitment underscores Ipca Laboratories' dedication to mitigating its environmental impact and aligning with industry standards for sustainability. As of now, there is no disclosed data on Scope 3 emissions, indicating a potential area for future focus. Overall, Ipca Laboratories is actively working towards reducing its carbon footprint while maintaining transparency in its emissions reporting.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
151,862,000
000,000,000
Scope 2
174,694,000
000,000,000
Scope 3
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ipca Laboratories's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ipca Laboratories is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ipca Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

GlaxoSmithKline Pharmaceuticals Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Wockhardt

IN
Pharmaceutical Preparation Manufacturing
Updated about 11 hours ago

Akums Drugs and Pharmaceuticals Limited

IN
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Ajanta Pharma

IN
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Torrent Pharmaceuticals

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Cipla

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers